MOVE-1 Study: Smartwatch Monitoring Feasibility in Head and Neck Cancer Survivors

A 2026 cross-sectional study by Karl Vietenhoff evaluated smartwatch-based monitoring in 35 head and neck cancer survivors. Participants wore a smartwatch for a median of 111 hours over a 7-day period, with data collected on heart rate, step count, and usability metrics. The study reported a recruitment rate of 50% and a median daily step count of 7,298.

Use Cases

• Assess feasibility of wearable-based monitoring based on adherence metrics like median wearing time (111 hours) and recruitment rate (50%).
• Evaluate patient-reported usability based on System Usability Scale (SUS) scores and frequency of display use.
• Analyze physical activity levels in a specific cancer cohort based on the reported median daily step count (7,298 steps).
• Investigate barriers to technology adoption based on reasons for non-participation cited in the study.

Strengths

• Includes specific, reported metrics: median wearing time of 111 hours (67% adherence), median daily step count of 7,298, and mean SUS score of 74.
• Provides comparative analysis between participants and non-participants regarding age and sex.
• Data is openly shared under a CC-BY-4.0 license, facilitating reuse.

Limitations

• Row count and column-level documentation are unknown, limiting assessment of dataset structure and variable semantics.
• The dataset is very small (231.7 KB), suggesting limited scope and sample size (35 participants).
• Data may reflect bias inherent to a single feasibility study from an unspecified geographic location.

Provenance

Source

Karl Vietenhoff via figshare

Collection Method

Cross-sectional study (MOVE-1) where participants wore a smartwatch for seven days.

Freshness

Last updated 2026-06-03 04:49:56.